David T. Davies

1.4k total citations
32 papers, 750 citations indexed

About

David T. Davies is a scholar working on Organic Chemistry, Molecular Biology and Molecular Medicine. According to data from OpenAlex, David T. Davies has authored 32 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 14 papers in Molecular Biology and 8 papers in Molecular Medicine. Recurrent topics in David T. Davies's work include Antibiotic Resistance in Bacteria (8 papers), Chemical Synthesis and Analysis (5 papers) and Cancer therapeutics and mechanisms (5 papers). David T. Davies is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Chemical Synthesis and Analysis (5 papers) and Cancer therapeutics and mechanisms (5 papers). David T. Davies collaborates with scholars based in United Kingdom, United States and Italy. David T. Davies's co-authors include Martin Everett, Andrew F. Parsons, Pamela Brown, J. M. Wilson, Steven Dabbs, Graham E. Jones, Marc Lemonnier, Colin W. G. Fishwick, Magdalena Zalacaín and David J. Procter and has published in prestigious journals such as Accounts of Chemical Research, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

David T. Davies

32 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David T. Davies United Kingdom 16 384 292 189 105 60 32 750
Barton J. Bradbury United States 15 257 0.7× 323 1.1× 130 0.7× 118 1.1× 71 1.2× 20 600
Eric Desarbre France 15 316 0.8× 182 0.6× 340 1.8× 212 2.0× 41 0.7× 26 720
Sebastián A. Testero Argentina 16 472 1.2× 236 0.8× 196 1.0× 122 1.2× 76 1.3× 37 812
Graciela Mahler Uruguay 17 388 1.0× 250 0.9× 306 1.6× 143 1.4× 104 1.7× 48 811
Samarendra N. Maiti Canada 16 455 1.2× 327 1.1× 229 1.2× 152 1.4× 49 0.8× 60 794
Karl A. Hansford Australia 19 395 1.0× 516 1.8× 142 0.8× 223 2.1× 170 2.8× 33 1.1k
Masami Ohtsuka Japan 17 550 1.4× 325 1.1× 289 1.5× 209 2.0× 53 0.9× 27 945
Renee A. Bouley United States 11 328 0.9× 317 1.1× 141 0.7× 90 0.9× 133 2.2× 30 752
Martina Hrast Slovenia 20 367 1.0× 566 1.9× 136 0.7× 89 0.8× 99 1.6× 55 892
Mosaad S. Mohamed Egypt 22 945 2.5× 294 1.0× 72 0.4× 106 1.0× 123 2.0× 64 1.2k

Countries citing papers authored by David T. Davies

Since Specialization
Citations

This map shows the geographic impact of David T. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Davies more than expected).

Fields of papers citing papers by David T. Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Davies. The network helps show where David T. Davies may publish in the future.

Co-authorship network of co-authors of David T. Davies

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Davies. A scholar is included among the top collaborators of David T. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Davies. David T. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zalacaín, Magdalena, Ian Morrissey, Stephen Hawser, et al.. (2024). Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 68(3). e0112023–e0112023. 6 indexed citations
2.
Everett, Martin, David T. Davies, Jérôme Castandet, et al.. (2023). Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS Infectious Diseases. 9(2). 270–282. 15 indexed citations
3.
Davies, David T. & Martin Everett. (2021). Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria. Accounts of Chemical Research. 54(9). 2055–2064. 27 indexed citations
4.
Everett, Martin & David T. Davies. (2021). Pseudomonas aeruginosa elastase (LasB) as a therapeutic target. Drug Discovery Today. 26(9). 2108–2123. 60 indexed citations
5.
Davies, David T., Jérôme Castandet, Michael S. Bodnarchuk, et al.. (2021). Virtual Screening Approach to Identifying a Novel and Tractable Series ofPseudomonas aeruginosaElastase Inhibitors. ACS Medicinal Chemistry Letters. 12(2). 217–227. 11 indexed citations
6.
Everett, Martin, Alicia Coelho, Jérôme Castandet, et al.. (2018). Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 62(5). 84 indexed citations
7.
Davies, David T., James Raftery, Íñigo J. Vitórica‐Yrezábal, et al.. (2017). The Synthesis of Group 10 and 11 Metal Complexes of 3,6,9‐Trithia‐1‐(2,6)‐pyridinacyclodecaphane and Their Use in A3‐Coupling Reactions. European Journal of Organic Chemistry. 2017(35). 5252–5261. 12 indexed citations
8.
Miles, Timothy J., Alan J. Hennessy, B.D. Bax, et al.. (2016). Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 26(10). 2464–2469. 33 indexed citations
9.
Czaplewski, Lloyd G., et al.. (2014). Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity. European Journal of Medicinal Chemistry. 86. 31–38. 47 indexed citations
10.
Miles, Timothy J., Gerald Brooks, Pamela Brown, et al.. (2011). Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 21(24). 7483–7488. 33 indexed citations
11.
Sucunza, David, Laura C. Miller, Matthew Helm, et al.. (2011). A stereoselective, Sm(ii)-mediated approach to decorated cis-hydrindanes: synthetic studies on faurinone and pleuromutilin. Organic & Biomolecular Chemistry. 9(7). 2433–2433. 22 indexed citations
12.
Sucunza, David, et al.. (2008). A Flexible, Stereoselective Approach to the Decorated cis‐Hydrindane Skeleton: Synthesis of the Proposed Structure of Faurinone. Chemistry - A European Journal. 14(23). 6862–6865. 25 indexed citations
13.
Marson, Charles M., et al.. (2007). A catalytic asymmetric protocol for the enantioselective synthesis of 3(2H)-furanones. Chemical Communications. 2494–2494. 39 indexed citations
14.
Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1999). Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists. Bioorganic & Medicinal Chemistry. 7(12). 2767–2773. 5 indexed citations
15.
Davies, David T., et al.. (1999). Copper(I) reactions in N-heterocycle synthesis: efficient preparation of substituted pyrrolidinones. Tetrahedron Letters. 40(49). 8615–8618. 26 indexed citations
16.
Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1998). Novel and Selective 5-HT2C/2B Receptor Antagonists as Potential Anxiolytic Agents:  Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines. Journal of Medicinal Chemistry. 41(10). 1598–1612. 53 indexed citations
17.
18.
Burton, George, David T. Davies, T. C. SMALE, et al.. (1990). Structure-activity relationships of some arylglycine analogues and catechol isosteres of BRL 36650, a 6.ALPHA.-formamido penicillin.. The Journal of Antibiotics. 43(5). 574–577. 2 indexed citations
19.
20.
Ashcroft, Alison E., David T. Davies, & James K. Sutherland. (1984). The synthesis of anthracyclinones-ii. Tetrahedron. 40(22). 4579–4583. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barton J. Bradbury Breakdown of academic impact, for papers by Eric Desarbre Breakdown of academic impact, for papers by Sebastián A. Testero Breakdown of academic impact, for papers by Graciela Mahler Breakdown of academic impact, for papers by Samarendra N. Maiti Breakdown of academic impact, for papers by Karl A. Hansford Breakdown of academic impact, for papers by Masami Ohtsuka Breakdown of academic impact, for papers by Renee A. Bouley Breakdown of academic impact, for papers by Martina Hrast Breakdown of academic impact, for papers by Mosaad S. Mohamed
Rankless by CCL
2026